Substances supporting mitochondria, i.e. a diet for promoting mitochondrial function

Mitochondria constitute specialized, semi-independent organelles situated within the cytoplasmic matrix of eukaryotic cells, possessing their own circular DNA genome alongside a fully operational protein synthesis machinery. They serve as the primary metabolic hub, orchestrating the catabolic and anabolic transformations of high-energy compounds—including carbohydrates, fatty acids, amino acids, and nucleotides—while concurrently producing adenosine triphosphate (ATP) via oxidative phosphorylation, thereby functioning as the cornerstone of cellular bioenergetics.

Mitochondria constitute extraordinarily intricate and dynamic intracellular structures wherein a multitude of fundamental biochemical processes occur, most notably the synthesis of adenosine triphosphate (ATP)—the universal energy currency indispensable for executing the vast majority of cellular reactions that demand substantial energy input. Beyond this pivotal role, these organelles facilitate critical metabolic pathways, including the tricarboxylic acid cycle (commonly referred to as the Krebs cycle) and the beta-oxidation of fatty acids, both of which ensure a continuous supply of energetic substrates to the cell. Furthermore, mitochondria play an indispensable part in maintaining acid-base balance (pH regulation), redox potential, and ionic homeostasis, thereby serving as the primary regulators of the intracellular environment. However, their functional scope extends far beyond mere energy provision: they are actively involved in governing cellular division (proliferation), apoptotic mechanisms (programmed cell death), and even neoplastic transformation, as substantiated by extensive scientific research [1]. Impairments in mitochondrial function—whether stemming from nutritional deficiencies (e.g., coenzyme Q10, alpha-lipoic acid) or the toxic effects of heavy metals (such as lead or mercury)—result in a marked decline in ATP production. The repercussions of such dysfunction are profound, encompassing the disruption of multiple metabolic pathways, heightened oxidative stress, accelerated tissue aging, and an elevated susceptibility to neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The clinical manifestations of mitochondrial dysfunction are highly heterogeneous and frequently multisystemic, rendering their diagnosis exceptionally challenging even in cases of identical genetic defects. Despite their microscopic dimensions, these organelles exert an immense influence on overall organismal health, dictating not only physical and cognitive performance but also the pace of aging processes. In recognition of their paramount importance, contemporary medicine is vigorously advancing a new field—mitochondrial medicine—which focuses on therapeutic interventions aimed at restoring the optimal functionality of these vital cellular components.

Representing an emergent paradigm within contemporary medical science, mitochondrial medicine constitutes a specialized discipline dedicated to safeguarding the structural and functional integrity of mitochondria—organelles critical to cellular energy metabolism—while emphasizing preventive strategies to mitigate damage to mitochondrial DNA (mtDNA). This field employs sophisticated prophylactic protocols designed to counteract oxidative stress and metabolic imbalances that compromise mitochondrial efficiency. Beyond prevention, it actively enhances cellular resilience by ensuring an optimal supply of essential cofactors, high-energy substrates, and antioxidant defenses, thereby reinforcing the body’s intrinsic homeostatic mechanisms. Unlike conventional symptom-focused diagnostic approaches, mitochondrial medicine leverages advanced subcellar analytical techniques to pinpoint the root causes of dysfunction at the mitochondrial level. This precision enables the implementation of tailored therapeutic interventions. The foundational premise of this discipline posits that a substantial proportion of chronic diseases—ranging from neurodegenerative and metabolic disorders to autoimmune conditions—originates from mitochondrial impairment. Consequently, restoring mitochondrial functionality emerges as a pivotal strategy for improving overall health outcomes and halting the progression of pathological processes.

Mitochondrial medicine operates on the premise that the majority of diseases stem from mitochondrial dysfunction—critical organelles responsible for cellular energy production, apoptosis regulation, and metabolic homeostasis. Its primary objective is to identify specific mitochondrial impairments, rectify them, and enhance mitochondrial performance to achieve disease remission or complete recovery. Given its cellular-level mechanism of action, mitochondrial therapy transcends traditional medical specializations, offering a comprehensive approach to systemic health. It is increasingly applied in: **autoimmune disorders**—where chronic inflammation originating at the cellular level is considered a key pathogenic driver; **oncology**—acknowledging that disruptions in oxidative phosphorylation within mitochondria facilitate uncontrolled tumor cell proliferation (as demonstrated by Otto Warburg’s Nobel Prize-winning research); **neurodegenerative diseases**—where the accumulation of mtDNA mutations in neurons (particularly in the substantia nigra of patients over 75) may correlate with hereditary predispositions to conditions such as Alzheimer’s and Parkinson’s; **type 2 diabetes**—where mitochondrial dysfunction in skeletal muscle cells disrupts glucose metabolism, and chronic oxidative stress exacerbates microvascular complications; **liver diseases** (NAFLD/NASH)—where structural mitochondrial abnormalities (e.g., megamitochondria formation) impair hepatocyte regeneration; **cardiovascular diseases**—where calcium ion homeostasis disruptions in cardiac mitochondria contribute to ischemic damage; and **aging processes**—where progressive mtDNA mutation accumulation accelerates cellular degradation, while mitochondrial optimization may decelerate this trajectory.

The efficient operation of mitochondria—cellular "power plants" tasked with adenosine triphosphate (ATP) synthesis—is contingent upon a continuous and adequate supply of specialized nutritional compounds from diverse biological sources. The primary metabolic substrates fueling the citric acid cycle and electron transport chain include: monosaccharides (chiefly glucose derived from complex carbohydrates), ketone bodies (generated via ketogenesis from fatty acids), and oxygen molecules essential for oxidative phosphorylation. Furthermore, to sustain the structural integrity of mitochondrial membranes and optimize energetic processes, the organism requires regular supplementation with the following bioactive compounds: 1. **B-vitamin complex** – particularly thiamine (B₁), riboflavin (B₂), niacin (B₃), and pantothenic acid (B₅), which serve as coenzymes in glycolysis, the citric acid cycle, and electron transport. Natural sources encompass organ meats (liver, kidneys), leafy green vegetables (e.g., kale, spinach), poultry, whole grains, and legumes. 2. **Trace elements and electrolytes** – including sulfur (a constituent of sulfur-containing amino acids), zinc (a cofactor for over 300 mitochondrial enzymes), magnesium (a membrane stabilizer and ATP activator), iron (central to hemoglobin and cytochrome-mediated oxygen transport), manganese (a component of superoxide dismutase), and selenium (an element of selenoproteins that protect against lipid peroxidation). 3. **Exogenous and endogenous antioxidants** – such as ascorbic acid (vitamin C), which neutralizes reactive oxygen species (ROS) generated during cellular respiration, thereby preventing damage to mitochondrial DNA (mtDNA) and membrane proteins. Rich sources include berries, bell peppers, broccoli, and wild herbs. 4. **L-carnitine** – a trimethylated amino acid responsible for transporting long-chain fatty acids (LCFA) across the mitochondrial membrane into the matrix, where they undergo β-oxidation to form acetyl-CoA. Dietary precursors are found in red meat (beef, pork) and dairy products. 5. **Alpha-lipoic acid (ALA)** – a universal cofactor for dehydrogenases involved in the decarboxylation of α-keto acids (e.g., pyruvate), capable of regenerating other antioxidants (vitamin E, glutathione) and modulating signaling pathways associated with aging (e.g., via sirtuin activation). The highest concentrations occur in the heart, kidneys, and bone marrow of slaughtered animals. 6. **Phosphocreatine and creatine** – high-energy phosphate compounds that buffer ATP pools in tissues with high energy demands (skeletal muscle, brain). Dietary sources include marine fish (tuna, herring) and mammalian meat. 7. **Coenzyme Q₁₀ (ubiquinone)** – a lipophilic electron carrier in the respiratory chain whose deficiency correlates with mitochondrial dysfunction in neurodegenerative diseases (e.g., Parkinson’s, Alzheimer’s) and cardiomyopathies. It is synthesized endogenously but also obtained from food—particularly calf liver, peanuts, and soybean oil. 8. **Cholecalciferol (vitamin D₃)** – a steroid prohormone exhibiting immunomodulatory, antiproliferative (inhibiting tumor angiogenesis), and neuroprotective effects by regulating the expression of mitochondrial genes (e.g., *PGC-1α*). Its cutaneous synthesis depends on UVB exposure, while dietary sources include fatty marine fish (Atlantic salmon, sardines), cod liver oil, and fortified dairy products. Deficiencies in these nutrients may lead to **mitochondrial dysfunction**—a condition characterized by reduced oxidative phosphorylation efficiency, excessive ROS production, and structural damage (e.g., fragmentation of the mitochondrial network). Clinical consequences include accelerated cellular aging, insulin resistance, neurodegenerative disorders, and cancer predisposition. **Mitochondrial medicine**—an interdisciplinary field integrating biochemistry, genetics, and nutrition science—focuses on identifying the root causes of these dysfunctions (e.g., mtDNA mutations, environmental toxins, chronic metabolic stress) and correcting them through **personalized nutritional and pharmacological interventions** (e.g., NAD⁺ precursors, mTOR inhibitors).